InvestorsHub Logo
Followers 168
Posts 8695
Boards Moderated 0
Alias Born 05/11/2010

Re: Gold prospector post# 222

Saturday, 10/27/2018 10:50:10 AM

Saturday, October 27, 2018 10:50:10 AM

Post# of 32755
This stock is way under the radar. Extremely undervalued with a Market Cap of $240K. Fully reporting bio-tech company trading on the OTC QB with a tiny share structure of only $12.6M O/S, Float 7M, A/S 249M with a Patent pending application for the treatment of Alzheimer’s disease.

Our Products   Dr. Saini is the inventor of U.S. Patent Application No. 16/031,898, derived from Patent Application No. 15/823,486, No. 15/493,535, No. 15/260,699, No. 15/006,939, No. 13/849,014, No. 13/309,468 and No. 12/361,808, and its foreign counterparts in Europe. He is one of our founders and a medical advisor to the Company. As a practicing physician, he is a gastrointestinal specialist, and often needs to apply a gastrostomy tube to an abdominal area of a patient for surgical procedures. In some cases, when a patient having dementia underwent such surgery, Dr. Saini observed that some of symptoms of dementia became noticeably improved for at least 24 hours or longer after the surgery. These observations led Dr. Saini to a hypothesis that stimulation of Omentum can improve conditions related to dementia and such improvement may occur because the stimulation of Omentum induces production and/or secretion of some biological agent(s) that can improve such conditions.   Based on these observations, Dr. Saini conducted intensive studies that led to the discovery of a potential breakthrough in the treatment of Alzheimer’s Disease. These breakthroughs are described in Dr. Saini’s pending patent applications, which we have licensed from Dr. Saini under the patent license agreement. More particularly, the pending patent applications describe in detail a variety of methods of isolating several biological agents from the Omentum and testing the agents for their activity in treating dementia conditions. The isolation and identification of active biological agents can be done with the Omentum tissue obtained from a patient or grown in a petri-dish. Accordingly, methods of producing the Omentum tissue, possibly on a large scale, are included in the applications.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.